• Advair Diskus 250 [Fluticasone Propionate + Salmeterol inhalation powder 250mcg | 50mcg x 60 doses] CANADIAN PHARMACEUTICAL GRADE [ASTHMA / LUNGS]

    Advair Diskus 250 [Fluticasone Propionate + Salmeterol inhalation powder 250mcg | 50mcg x 60 doses] CANADIAN PHARMACEUTICAL GRADE [ASTHMA / LUNGS]

    ADVAIR DISKUS 250 [FLUTICASONE PROPIONATE + SALMETEROL INHALATION POWDER 250MCG | 50MCG X 60 DOSES] – CANADIAN PHARMACEUTICAL GRADE COMBINATION RESEARCH INHALER

    Advair Diskus 250 contains a dual-active combination of Fluticasone Propionate (250mcg) and Salmeterol (50mcg) per inhalation dose. It is a Canadian pharmaceutical grade dry powder inhalation system designed for research applications focused on respiratory receptor modulation, anti-inflammatory activity, and beta-2 adrenergic pathway studies.

    Researchers use this formulation to evaluate the synergistic effects between corticosteroid-mediated anti-inflammatory signaling and beta-2 adrenergic receptor agonism within controlled pulmonary systems. Each device provides 60 precisely metered doses in a sealed, dry-powder delivery system.

    The Details:

    • Active Ingredients: Fluticasone Propionate 250mcg + Salmeterol Xinafoate 50mcg per dose

    • Quantity: 60 metered doses per Diskus device

    • Form: Inhalation powder (Dry Powder Inhaler – DPI)

    • Source: Canadian pharmaceutical grade

    Key Features of Advair Diskus 250:

    • Dual Mechanism Research Tool: Combines corticosteroid and beta-2 agonist for receptor pathway comparison.

    • Anti-Inflammatory Studies: Supports investigations into glucocorticoid receptor signaling and cytokine modulation.

    • Adrenergic Pathway Research: Enables analysis of long-acting beta-2 receptor engagement.

    • Synergistic Modeling: Designed for combined pathway studies in pulmonary response experiments.

    • Canadian Verified Quality: Produced to pharmaceutical standards and third-party verified.

    For more products, visit: https://www.canadasteroiddepot.is/

    $270.00
  • Ventolin HFA 100mcg x 200 Doses [Pressurized Salbutamol Inhaler] | CANADIAN PHARMACEUTICAL GRADE [ASTHMA / LUNGS]

    Ventolin HFA 100mcg x 200 Doses [Pressurized Salbutamol Inhaler] | CANADIAN PHARMACEUTICAL GRADE [ASTHMA / LUNGS]

    VENTOLIN HFA 100MCG X 200 DOSES [PRESSURIZED SALBUTAMOL INHALER] – CANADIAN PHARMACEUTICAL GRADE BRONCHODILATOR

    Ventolin HFA 100mcg (Salbutamol Sulfate) is a Canadian pharmaceutical grade metered-dose inhaler (MDI) formulated for research into beta-2 adrenergic receptor activation, airway smooth muscle relaxation, and pulmonary function modulation.

    Each canister delivers 200 precisely metered inhalations, providing 100mcg of Salbutamol per actuation. Researchers use this compound to study adrenergic signaling, airway responsiveness, and the pharmacokinetic properties of aerosolized compounds under controlled laboratory conditions.

    The Details:

    • Active Ingredient: Salbutamol Sulfate (100mcg per actuation)

    • Quantity: 200 metered doses per inhaler

    • Form: Pressurized inhalation aerosol (HFA-propelled)

    • Source: Canadian pharmaceutical grade

    Key Features of Ventolin HFA:

    • Beta-2 Adrenergic Receptor Agonist: Enables research into receptor activation and bronchodilatory mechanisms.

    • Aerosol Delivery Studies: Supports investigations into inhaled compound distribution and pulmonary uptake.

    • Smooth Muscle Research: Used in modeling airway tone modulation and adrenergic receptor signaling.

    • Precision Metered Dosing: Ensures reproducibility across inhalation-based test systems.

    $50.00
  • EXEMESTANE 25MG X 45 TABLETS – HIKMA

    EXEMESTANE 25MG X 45 TABLETS – HIKMA RESEARCH COMPOUND

    Exemestane 25mg is a steroidal aromatase inhibitor produced by Hikma Laboratories, formulated for laboratory research into estrogen biosynthesis inhibition, hormonal regulation, and endocrine signaling pathways. It functions as an irreversible aromatase inactivator, providing researchers a precise model to study the suppression of estrogen formation from androgens in cellular and biochemical systems.

    Researchers utilize Exemestane in controlled environments to explore hormonal balance, enzyme kinetics, and the downstream effects of aromatase modulation. Its structure and mechanism make it suitable for comparative studies alongside non-steroidal aromatase inhibitors and selective estrogen receptor modulators (SERMs).

    The Details:

    • Dosage: 25mg per tablet

    • Quantity: 45 tablets per container

    • Form: Oral research tablets

    • Packaging: Sealed, tamper-proof container for product stability

    • Source: Manufactured by Hikma Laboratories under strict quality and purity standards

    • Purity: ≥99% verified by HPLC and mass spectrometry

    Key Features of Exemestane:

    • Aromatase Inactivation: Irreversible suppression of estrogen synthesis for endocrine pathway modeling.

    • Enzymatic Pathway Research: Supports analysis of CYP19A1 enzyme kinetics and feedback regulation.

    • Hormonal Regulation Studies: Enables evaluation of estrogen/androgen balance in tissue models.

    • Comparative Inhibitor Analysis: Useful for contrasting steroidal and non-steroidal aromatase inhibitors.

    • Hikma Manufacturing Quality: Laboratory-produced and independently verified for purity and potency.

    For more products, visit: https://www.canadasteroiddepot.is/

    $75.00
  • Lantus 100iu/mL 5x3mL Insulin Pens | CANADIAN PHARMACEUTICAL GRADE

    Lantus 100iu/mL 5x3mL Insulin Pens | CANADIAN PHARMACEUTICAL GRADE

    LANTUS 100IU/ML 5×3ML INSULIN PENS – CANADIAN PHARMACEUTICAL GRADE LONG-ACTING INSULIN ANALOG

    Lantus (Insulin Glargine) 100IU/mL is a Canadian pharmaceutical grade long-acting insulin analog, supplied in sterile prefilled pens for controlled and precise delivery in metabolic and biochemical research. This formulation provides a stable and extended insulin release profile, making it valuable for studies involving glucose regulation, receptor kinetics, and long-duration insulin signaling models.

    Each package includes five 3mL prefilled pens, each containing 100IU/mL of Insulin Glargine. Manufactured to Canadian pharmaceutical-grade standards, this compound ensures exceptional consistency, sterility, and precision.

    The Details:

    • Concentration: 100IU/mL

    • Quantity: 5 pens × 3mL each

    • Form: Prefilled injectable pens (Insulin Glargine)

    • Source: Canadian pharmaceutical grade

    Key Features of Lantus 100IU/mL:

    • Insulin Receptor Research: Enables long-term modeling of insulin receptor activity and signaling.

    • Sustained Kinetics: Provides a gradual and extended insulin release curve for stable experimental results.

    • Metabolic Regulation Studies: Ideal for evaluating glucose utilization and endocrine function.

    • Precision Delivery: Prefilled design ensures consistent and accurate dosing.

    • Canadian Pharmaceutical Quality: Authenticated and independently tested to ensure reliability.

    For more products, visit: https://www.canadasteroiddepot.is/

    $210.00
  • Humalog KwikPen 200iu/mL [5x3mL Insulin Pens | 3000iu TOTAL] | CANADIAN PHARMACEUTICAL GRADE

    Humalog KwikPen 200iu/mL [5x3mL Insulin Pens | 3000iu TOTAL] | CANADIAN PHARMACEUTICAL GRADE

    HUMALOG KWIKPEN 200IU/ML 5×3ML INSULIN PENS – CANADIAN PHARMACEUTICAL GRADE INSULIN ANALOG

    Humalog KwikPen 200IU/mL is a Canadian pharmaceutical grade rapid-acting insulin analog (Insulin Lispro) supplied in prefilled injection pens for precision dosing and stability. This formulation is used in laboratory research to study glucose regulation, receptor activity, and metabolic signaling in controlled settings.

    Each pack includes five 3mL prefilled pens, each containing 200IU/mL of high-purity Insulin Lispro. Manufactured to exacting Canadian pharmaceutical standards, every pen ensures consistent delivery and stability for extended research use.

    The Details:

    • Concentration: 200IU/mL

    • Quantity: 5 pens × 3mL each

    • Form: Prefilled injectable pens (Insulin Lispro)

    • Packaging: Sterile, sealed, tamper-evident containers

    • Source: Canadian pharmaceutical grade

    Key Features of Humalog KwikPen:

    • Insulin Receptor Studies: Supports investigations into insulin signaling and glucose uptake pathways.

    • Rapid-Action Kinetics: Ideal for modeling fast-acting insulin analog activity in controlled systems.

    • Consistent Delivery: Prefilled pens ensure reproducible dose precision across applications.

    • Metabolic Research Utility: Enables studies on carbohydrate metabolism and energy regulation.

    • Canadian Verified Quality: Authenticated and tested to pharmaceutical-grade standards.

    For more products, visit: https://www.canadasteroiddepot.is/

    $192.00
  • Semaglutide Injection 2.4mg Pen (9.6mg TOTAL)  (3.2mg/mL) - 4 Doses of 2.4mg | CANADIAN PHARMACEUTICAL GRADE

    Semaglutide Injection 2.4mg Pen (9.6mg TOTAL) (3.2mg/mL) – 4 Doses of 2.4mg | CANADIAN PHARMACEUTICAL GRADE

    Wegovy (Semaglutide) 2.4mg/dose is a Canadian pharmaceutical grade GLP-1 receptor agonist provided in a prefilled injectable pen for precise, single-dose administration. It is widely used in research to study metabolic regulation, glucose homeostasis, and energy balance pathways.

    This high-quality formulation delivers consistent dosage accuracy and stability for long-term experimental use, allowing researchers to evaluate the physiological effects of GLP-1 receptor activation on metabolic and appetite-related mechanisms.

    The Details:

    • Dosage: 2.4mg semaglutide per dose

    • Form: Prefilled injection pen

    • Quantity: Single-use pen, ready for controlled application

    • Packaging: Sterile, tamper-evident pen in sealed packaging

    • Source: Canadian pharmaceutical grade

    Key Features of Wegovy 2.4mg:

    • Metabolic Regulation Research: Supports studies on energy homeostasis and glucose signaling.

    • GLP-1 Pathway Analysis: Enables examination of incretin-related receptor pathways.

    • Dose Precision: Prefilled delivery system ensures reliable and reproducible dosing.

    • Appetite and Energy Studies: Investigated for effects on satiety and caloric intake regulation.

    • Pharmaceutical Authenticity: Canadian-produced and independently verified.

    $400.00
  • GLP-3 RTA  [Triple G] 20mg – Revolutionary weight loss BRAND NEW ( Quantitative and qualitative analysis second image)

    GLP-3 RTA [Triple G] 20mg – Revolutionary weight loss BRAND NEW ( Quantitative and qualitative analysis second image)

    01

    GLP-3 RTA [Triple G] 20mg is a next-level peptide for athletes, biohackers, and fitness enthusiasts focused on fat loss, appetite control, and metabolic support. Known for its powerful triple-action formula, Triple G is designed to help optimize body composition, support healthy blood sugar regulation, and keep you feeling energized while cutting or recompositioning. Perfect for anyone looking to enhance results alongside training and nutrition.

    Benefits & Info:

    • Supports fat loss and improved body composition

    • Helps regulate appetite and cravings

    • Supports healthy blood sugar and metabolic function

    • Popular among athletes, biohackers, and fitness-focused users

    • Convenient and precise dosing for consistent results

    • Often used during cutting, recomp, or performance-focused phases

    • 20mg per vial for easy stacking and use

    $274.00
  • 5 PACK – BPC-157 10mg ( Quantitative and qualitative analysis second image)

    01

    5 PACK – BPC-157 10mg

    Dosage – ranges from 250mcg daily to 750mcg daily.  Personally on our 200 pound pitbull who was injured , we run 750mcg daily for 4-6 weeks.

    What is BPC-157.

    Body protecting compound (BPC-157) is a group of amino acids from the recovery peptides. It has a great ability in recovering pain and healing injuries. Moreover, it is used to treat some intestinal problems like ulcers. It has some anti-inflammatory effects in healing arthritis and similar inflammations. Researchers are also studying the efficacy of this peptide in repairing certain organ damages.

    It has many health benefits and organizations are still undergoing research to discover more.  Some of the research that involved BPC-157 products were muscles, teeth, bone, and intestinal studies. Since it has the potential to cure severe complications, rigorous in-vitro research is required first.

    Versatile Benefits

    BPC-157 isn’t limited to just muscle recovery. It offers a wide range of benefits, including:

    1. Gastrointestinal Health

    Surprisingly, BPC-157 has shown remarkable effects on gastrointestinal health. It can address issues like:

    • Bone degeneration
    • Joint discomfort
    • Intestinal damage
    • Ulcers

    This wide spectrum of applications makes it a versatile choice for those looking to improve their overall well-being.

    2. Anti-Inflammatory Properties

    BPC-157 is known for its anti-inflammatory properties, which are crucial for anyone involved in strenuous physical activities. It can help reduce inflammation, protecting against common conditions like muscle soreness and joint pain.

    3. Brain and Organ Protection

    Intriguingly, BPC-157 goes beyond just physical benefits. It offers protection against brain disorders and organ damage. This makes it an appealing option for individuals looking to safeguard their long-term health.

     

    The similarities between TB-500 and BPC-157

    The main similarities between TB-500 and BPC-157 are as follows:

    • Both research peptides have demonstrated anti-inflammatory properties
    • Both research peptides promote angiogenesis (i.e. the formation of new blood vessels)
    • Some researchers contend that TB-500 and BPC-157 increase blood circulation by different mechanisms, but the end result is the same

    The differences between TB-500 and BPC-157

    There are some obvious differences between these two research peptides.

    • TB-500 has a systemic effect, which means it works regardless of where the injection is made
    • BPC-157 has a localized effect and must be injected near the site of the injury
    • TB-500 works to distribute actin, whereas BPC-157 is directly responsible for increasing actin production.

    Keep in mind that the only way to definitively prove the difference between TB-500 and BPC-157 would be to conduct a large-scale clinical trial in which the same type of injury is being treated.

    While this type of research has yet to be conducted, it is clear that BPC-157 and TB-500 do not counteract one another.

    If anything, anecdotal evidence shows that they work synergistically to speed up the healing process and further accelerate the rate of recovery.

    Try Similar Products

    $335.00$345.00

Main Menu